220 related articles for article (PubMed ID: 31515056)
1. No light without the dark: Perspectives and hindrances for translation of cardiac optogenetics.
Richter C; Bruegmann T
Prog Biophys Mol Biol; 2020 Aug; 154():39-50. PubMed ID: 31515056
[TBL] [Abstract][Full Text] [Related]
2. Opsin spectral sensitivity determines the effectiveness of optogenetic termination of ventricular fibrillation in the human heart: a simulation study.
Karathanos TV; Bayer JD; Wang D; Boyle PM; Trayanova NA
J Physiol; 2016 Dec; 594(23):6879-6891. PubMed ID: 26941055
[TBL] [Abstract][Full Text] [Related]
3. Systemic gene transfer enables optogenetic pacing of mouse hearts.
Vogt CC; Bruegmann T; Malan D; Ottersbach A; Roell W; Fleischmann BK; Sasse P
Cardiovasc Res; 2015 May; 106(2):338-43. PubMed ID: 25587047
[TBL] [Abstract][Full Text] [Related]
4. Optogenetic Termination of Cardiac Arrhythmia: Mechanistic Enlightenment and Therapeutic Application?
Sasse P; Funken M; Beiert T; Bruegmann T
Front Physiol; 2019; 10():675. PubMed ID: 31244670
[TBL] [Abstract][Full Text] [Related]
5. Optogenetics gets to the heart: A guiding light beyond defibrillation.
Crocini C; Ferrantini C; Pavone FS; Sacconi L
Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):132-139. PubMed ID: 28506694
[TBL] [Abstract][Full Text] [Related]
6. Optical Manipulation of Perfused Mouse Heart Expressing Channelrhodopsin-2 in Rhythm Control.
Wang X; Cheng Y
Methods Mol Biol; 2021; 2191():377-390. PubMed ID: 32865755
[TBL] [Abstract][Full Text] [Related]
7. Energy-Reduced Arrhythmia Termination Using Global Photostimulation in Optogenetic Murine Hearts.
Quiñonez Uribe RA; Luther S; Diaz-Maue L; Richter C
Front Physiol; 2018; 9():1651. PubMed ID: 30542292
[TBL] [Abstract][Full Text] [Related]
8. Towards the clinical translation of optogenetic skeletal muscle stimulation.
Gundelach LA; Hüser MA; Beutner D; Ruther P; Bruegmann T
Pflugers Arch; 2020 May; 472(5):527-545. PubMed ID: 32415463
[TBL] [Abstract][Full Text] [Related]
9. Termination of re-entrant atrial tachycardia via optogenetic stimulation with optimized spatial targeting: insights from computational models.
Boyle PM; Murphy MJ; Karathanos TV; Zahid S; Blake RC; Trayanova NA
J Physiol; 2018 Jan; 596(2):181-196. PubMed ID: 29193078
[TBL] [Abstract][Full Text] [Related]
10. Optogenetics for in vivo cardiac pacing and resynchronization therapies.
Nussinovitch U; Gepstein L
Nat Biotechnol; 2015 Jul; 33(7):750-4. PubMed ID: 26098449
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of Using Adjunctive Optogenetic Technologies in Cardiomyocyte Phenotyping - from the Single Cell to the Whole Heart.
Bub G; Daniels MJ
Curr Pharm Biotechnol; 2020; 21(9):752-764. PubMed ID: 30961485
[TBL] [Abstract][Full Text] [Related]
12. Cardiac applications of optogenetics.
Ambrosi CM; Klimas A; Yu J; Entcheva E
Prog Biophys Mol Biol; 2014 Aug; 115(2-3):294-304. PubMed ID: 25035999
[TBL] [Abstract][Full Text] [Related]
13. Optogenetic termination of atrial fibrillation in mice.
Bruegmann T; Beiert T; Vogt CC; Schrickel JW; Sasse P
Cardiovasc Res; 2018 Apr; 114(5):713-723. PubMed ID: 29293898
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cardiac tissue electrophysiological properties with light-sensitive proteins.
Nussinovitch U; Shinnawi R; Gepstein L
Cardiovasc Res; 2014 Apr; 102(1):176-87. PubMed ID: 24518144
[TBL] [Abstract][Full Text] [Related]
15. Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations.
Bruegmann T; Boyle PM; Vogt CC; Karathanos TV; Arevalo HJ; Fleischmann BK; Trayanova NA; Sasse P
J Clin Invest; 2016 Oct; 126(10):3894-3904. PubMed ID: 27617859
[TBL] [Abstract][Full Text] [Related]
16. Optogenetic control of contractile function in skeletal muscle.
Bruegmann T; van Bremen T; Vogt CC; Send T; Fleischmann BK; Sasse P
Nat Commun; 2015 Jun; 6():7153. PubMed ID: 26035411
[TBL] [Abstract][Full Text] [Related]
17. Optogenetic termination of ventricular arrhythmias in the whole heart: towards biological cardiac rhythm management.
Nyns ECA; Kip A; Bart CI; Plomp JJ; Zeppenfeld K; Schalij MJ; de Vries AAF; Pijnappels DA
Eur Heart J; 2017 Jul; 38(27):2132-2136. PubMed ID: 28011703
[TBL] [Abstract][Full Text] [Related]
18. Recent Progress of Development of Optogenetic Implantable Neural Probes.
Zhao H
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800085
[TBL] [Abstract][Full Text] [Related]
19. Optical capture and defibrillation in rats with monocrotaline-induced myocardial fibrosis 1 year after a single intravenous injection of adeno-associated virus channelrhodopsin-2.
Li J; Wang L; Luo J; Li H; Rao P; Cheng Y; Wang X; Huang C
Heart Rhythm; 2021 Jan; 18(1):109-117. PubMed ID: 32781160
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cardiac optogenetics by vitamin A.
Keshmiri Neghab H; Goliaei B; Saboury AA; Esmaeeli Djavid G; Pornour M; Hong J; Grusch M
Biofactors; 2019 Nov; 45(6):983-990. PubMed ID: 31509323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
